Victormed Spółka z Ograniczoną Odpowiedzialnością w Likwidacji (KRS 0000509909, NIP 9571075042) is a Polish company, headquartered in Gdańsk, Pomorskie voivodeship. VICTORMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since May 16, 2014.
Entity dissolved
The data shown reflects the last known state before removal.
Negative equity
Negative equity in 3 of 5 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile (archived data) - Victormed
Identity
- Name
- Victormed Spółka z Ograniczoną Odpowiedzialnością w Likwidacji
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 16, 2014
- Registry status as of
- July 17, 2026
- Latest entry
- July 17, 2026
- Founding act
- AKT NOTARIALNY SPORZĄDZONY W DNIU 25.02.2014 R. PRZEZ NOTARIUSZA EWĘ OSYPIŃSKĄ - BALCERZAK, PROWADZĄCĄ KANCELARIĘ NOTARI…
Articles of association history (2)
- February 25, 2014: AKT NOTARIALNY SPORZĄDZONY W DNIU 25.02.2014 R. PRZEZ NOTARIUSZA EWĘ OSYPIŃSKĄ - BALCERZAK, PROWADZĄCĄ KANCELARIĘ NOTARIALNĄ PRZY UL. GRUNWALDZKIEJ 492/2, 80-309 GDAŃSK - OLIWA REPERTORIUM A NR 722/2014
- November 25, 2021: AKT NOTARIALNY Z 25.11.2021R. REP. A NR 18717/2021, NOTARIUSZ TOMASZ BINKOWSKI, KANCELARIA NOTARIALNA W GDAŃSKU, ZMIENIONO § 5
Activities
Other activities
Last known registered address
Archived data - last known state
- Address
- WAJDELOTY, 12, 80-437, GDAŃSK, POLSKA
- Voivodeship
- POMORSKIE
- District
- M. GDAŃSK
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Victormed
Credibility rating
1 / 100
Very poor credibility
Insolvency risk
closed
Significant formal threat
Closure risk
99
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/12 yrs
Board changes
3
3/12 yrs
PKD changes
1
1/12 yrs
Name changes
1
1/12 yrs
Data from 12 years of registry activity.
Credibility history
Payment reliability score from 2018–2022
Current: F (1/100)
Trend: stable (0.0 pts/year)
Spółka została rozwiązana lub wykreślona z rejestru – wskaźnik wiarygodności płatniczej nie ma już zastosowania. Nie należy podejmować nowej współpracy handlowej z podmiotem nieistniejącym.
Trade credit limit history
Standard limit from 2018–2022
Current: 0 PLN
Safe: 0 PLN
Operational status - Victormed
Status as of the last registry entry
Founded
May 16, 2014
12 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GDAŃSK
POMORSKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
10.0 K PLN
200 shares total
Shareholders
4
shareholders
Board
N/A
Filed years
5 years
2018–2022 · profitable: 0/5
Registry entries
31
latest: July 17, 2026
Risk signals
Revenue
N/A
2022
Net profit
N/A
2022
Assets
N/A
2022
Equity
N/A
2022
EBITDA
N/A
2022
no depreciation data
Valuation
0 PLN
closed
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Victormed.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
